Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.

Stoian, Anca Pantea; Banerjee, Yajnavalka; Rizvi, Ali A; Rizzo, Manfredi

Stoian, Anca Pantea; Banerjee, Yajnavalka; Rizvi, Ali A; Rizzo, Manfredi.

Stoian AP; Diabetes, Nutrition and Metabolic Diseases, University of Bucharest, Bucharest, Romania.
Banerjee Y; Department of Biochemistry, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Rizvi AA; Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, Georgia, USA.
Rizzo M; Department of Medicine, University of South Carolina, Columbia, South Carolina, USA.

Metab Syndr Relat Disord ; 18(4): 173-175, 2020 05.

Article in English | MEDLINE | ID: covidwho-46166

Subject(s)

Coronavirus Infections/complications; Diabetes Complications/immunology; Diabetes Complications/virology; Diabetes Mellitus/immunology; Pneumonia, Viral/complications; COVID-19; Coronavirus Infections/therapy; Diabetes Complications/therapy; Diabetes Mellitus/therapy; Disease Susceptibility; Humans; Pandemics; Pneumonia, Viral/therapy

Keywords

COVID-19; cardiovascular disease; endothelial dysfunction; insulin resistance; obesity; type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Diabetes Complications / Diabetes Mellitus Topics: Long Covid Limits: Humans Language: English Journal: Metab Syndr Relat Disord Journal subject: Metabolism Year: 2020 Document Type: Article Affiliation country: Met.2020.0037

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google